News About: Pharm. Industry
Forxiga is expected to be in competitive relationship with DPP-4 inhibitor on the patient's initial treatment regimen
On August 16, Ministry of Health and Welfare pre-announced insurance benefit range of 'Forxiga'. Its indication was limited to monotherapy or combination therapy with Metformin or Sulfonylurea family drug. Therefore, ...
Korean Pharmaceutical Association decided to cooperate with group of national movement for Generic Name Prescription and eradication of illegal kickback
Korean Pharmaceutical Association decided to cooperate with group of national movement for Generic Name Prescription and eradication of illegal kickback.
On August 14, Korean Pharmaceutical Association announced that...
Imports and exports related to health care industry have increased steadily after Korea -EU FTA
According to the 'Health Care Industry Brief' recently released by Korea Health Industry Development Institute, imports and exports related to health care industry have increased steadily after Korea -EU FTA entered i...
10 domestic and multinational pharmaceutical companies jumped into the development of Humira biosimilar
With the patent expiration of AbbVie's 'Humira' ahead, 10 domestic and multinational pharmaceutical companies are jumping into development of Humira biosimilar.
Humira records annual domestic sales of 45 billion won ...
Amgen's ‘Neulasta’ market enters into competition system
Amgen's mega blockbuster biopharmaceutical Neulasta (neutropenia treatment) market enters into competition system, because domestic top pharmaceutical companies also received final approval of biobetter recently.
Rep...
It was identified that some of the medicines supplied in a large hospital participates in the ‘1 won bidding’ frequently
It was identified that some of the medicines supplied in a large hospital participates in the ‘1 won bidding’ frequently.
According to the recent analysis of drug sales top 50 list which won 'low price bid(less than ...
It was identified that most of foreign direct investment of domestic pharmaceutical industry was for the purpose of entry into the local market
It was identified that most of foreign direct investment of domestic pharmaceutical industry was for the purpose of entry into the local market.
Korea Health Industry Development Institute announced the analysis thro...
36 listed pharmaceutical companies recorded sales of 4.1505 billion won which increased by 8.4% compared to the same period last year
On August 14, according to the business performance of 36 companies in the first half of 2014 based on each financial statements, they recorded sales of 4.1505 billion won which increased by 8.4% compared to the same ...
DPP-4 inhibitor is expected to strive against SGLT-2 inhibitor in earnest in type 2 diabetes drug market from next month
DPP-4 inhibitor is expected to strive against SGLT-2 inhibitor in earnest in type 2 diabetes drug market from next month. Ministry of Health and Welfare preannounced administrative notice of 'Details about the applica...
Generic developing pharmaceutical companies have been in ligation in order to invalidate a subsequent patent of Crestor
On August 17, according to the pharmaceutical industry, generic developing pharmaceutical companies which manufacture generic of Crestor that released in April, has been in ligation in order to invalidate a subsequent...
